Investor Presentaiton slide image

Investor Presentaiton

Nestlé Health Science • . Sales Organic growth Real internal growth Underlying TOP margin vs LY CHF 3.3 bn 3.5% -1.9% 13.0% -70 bps Organic growth increasing sequentially, supported by post-COVID normalization • Consumer Care saw negative growth, with growth in VMS turning positive in the second quarter • Medical nutrition recorded double-digit growth, led by acute medical care, pediatric and allergy products • Margin -70 bps due to cost inflation 16 July 27, 2023 Nestlé half-year results 2023 Slee NATURE'S BOUN Sleep3 SOMMINS Nestle Good food, Good life
View entire presentation